167 related articles for article (PubMed ID: 3917470)
1. Molecular species of platelet-activating factor generated by human neutrophils challenged with ionophore A23187.
Oda M; Satouchi K; Yasunaga K; Saito K
J Immunol; 1985 Feb; 134(2):1090-3. PubMed ID: 3917470
[TBL] [Abstract][Full Text] [Related]
2. Application of selected ion monitoring to determination of platelet-activating factor.
Satouchi K; Oda M; Yasunaga K; Saito K
J Biochem; 1983 Dec; 94(6):2067-70. PubMed ID: 6423622
[TBL] [Abstract][Full Text] [Related]
3. Species-specific variations in the molecular heterogeneity of the platelet-activating factor.
Ramesha CS; Pickett WC
J Immunol; 1987 Mar; 138(5):1559-63. PubMed ID: 3100641
[TBL] [Abstract][Full Text] [Related]
4. Release of platelet-activating factor and the metabolism of leukotriene B4 by the human neutrophil when studied in a cell superfusion model.
Cluzel M; Undem BJ; Chilton FH
J Immunol; 1989 Dec; 143(11):3659-65. PubMed ID: 2555414
[TBL] [Abstract][Full Text] [Related]
5. 1-Acyl-2-acetyl-sn-glycero-3-phosphocholine from stimulated human polymorphonuclear leukocytes.
Satouchi K; Oda M; Saito K
Lipids; 1987 Apr; 22(4):285-7. PubMed ID: 3110532
[TBL] [Abstract][Full Text] [Related]
6. Determination of AGEPC generated from human neutrophils and rat skin and muscle tissues by a selected ion monitoring technique of GC/MS.
Saito K; Satouchi K; Oda M; Nakayama R
Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():701-3. PubMed ID: 2936200
[No Abstract] [Full Text] [Related]
7. Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).
Shaw JO; Pinckard RN; Ferrigni KS; McManus LM; Hanahan DJ
J Immunol; 1981 Sep; 127(3):1250-5. PubMed ID: 6267133
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of platelet activating factor using fast atom bombardment/tandem mass spectrometry.
Haroldsen PE; Gaskell SJ
Biomed Environ Mass Spectrom; 1989 Jun; 18(6):439-44. PubMed ID: 2504312
[TBL] [Abstract][Full Text] [Related]
9. Analysis of effector cell-derived lyso platelet activating factor by electron capture negative ion mass spectrometry.
Christman BW; Gay JC; Christman JW; Prakash C; Blair IA
Biol Mass Spectrom; 1991 Sep; 20(9):545-52. PubMed ID: 1782204
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of platelet activating factor treated with pentafluorobenzoyl chloride using gas chromatography/negative ion chemical ionization mass spectrometry.
Shindo K; Hashimoto Y
Drugs Exp Clin Res; 1991; 17(7):343-9. PubMed ID: 1794300
[TBL] [Abstract][Full Text] [Related]
11. Differential platelet-activating factor synthesis by monocytes and polymorphonuclear leukocytes from subjects with localized aggressive periodontitis.
Shin CR; Moores J; Best AM; Tew JG; Schenkein HA; Barbour SE
J Periodontal Res; 2007 Jun; 42(3):202-11. PubMed ID: 17451539
[TBL] [Abstract][Full Text] [Related]
12. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J
J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649
[TBL] [Abstract][Full Text] [Related]
13. Ontogeny of the responsiveness to intravenous platelet-activating factor.
Angle MJ; Pinckard RN; Showell HJ; McManus LM
Lab Invest; 1987 Sep; 57(3):321-8. PubMed ID: 3626521
[TBL] [Abstract][Full Text] [Related]
14. Isolation and identification of embryo-derived platelet-activating factor in mice.
Kodama H; Muto H; Maki M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul; 41(7):899-906. PubMed ID: 2794622
[TBL] [Abstract][Full Text] [Related]
15. Structure elucidation of platelet activating factor derived from human neutrophils.
Clay KL; Murphy RC; Andres JL; Lynch J; Henson PM
Biochem Biophys Res Commun; 1984 Jun; 121(3):815-25. PubMed ID: 6430285
[TBL] [Abstract][Full Text] [Related]
16. Human neutrophil platelet-activating factor: molecular heterogeneity in unstimulated and ionophore-stimulated cells.
Ramesha CS; Pickett WC
Biochim Biophys Acta; 1987 Sep; 921(1):60-6. PubMed ID: 3113489
[TBL] [Abstract][Full Text] [Related]
17. Micellar electrokinetic capillary chromatographic analysis of platelet activating factor in human blood by indirect ultraviolet detection.
He J; Li H; Li X
Ann Ist Super Sanita; 1996; 32(3):375-80. PubMed ID: 9028060
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of lyso-platelet activating factor molecular species from human neutrophils by mass spectrometry.
Haroldsen PE; Clay KL; Murphy RC
J Lipid Res; 1987 Jan; 28(1):42-9. PubMed ID: 3104521
[TBL] [Abstract][Full Text] [Related]
19. Release of newly synthesized platelet-activating factor (PAF) from human polymorphonuclear leukocytes under in vivo conditions. Contribution of PAF-releasing factor in serum.
Miwa M; Sugatani J; Ikemura T; Okamoto Y; Ino M; Saito K; Suzuki Y; Matsumoto M
J Immunol; 1992 Feb; 148(3):872-80. PubMed ID: 1730879
[TBL] [Abstract][Full Text] [Related]
20. Analysis of platelet activating factor in human saliva by gas chromatography/mass spectrometry.
Christman BW; Blair IA
Biomed Environ Mass Spectrom; 1989 Apr; 18(4):258-64. PubMed ID: 2706378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]